25 XP   0   0   10

Biotage AB
Buy, Hold or Sell?

Let's analyse Biotage together

PenkeI guess you are interested in Biotage AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotage AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotage AB

I send you an email if I find something interesting about Biotage AB.

Quick analysis of Biotage (30 sec.)










What can you expect buying and holding a share of Biotage? (30 sec.)

How much money do you get?

How much money do you get?
kr0.24
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
kr45.66
Expected worth in 1 year
kr70.87
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
kr27.85
Return On Investment
16.8%

For what price can you sell your share?

Current Price per Share
kr165.50
Expected price per share
kr130.40 - kr170.40
How sure are you?
50%

1. Valuation of Biotage (5 min.)




Live pricePrice per Share (EOD)

kr165.50

Intrinsic Value Per Share

kr36.67 - kr67.31

Total Value Per Share

kr82.34 - kr112.97

2. Growth of Biotage (5 min.)




Is Biotage growing?

Current yearPrevious yearGrowGrow %
How rich?$334.2m$141m$150.9m51.7%

How much money is Biotage making?

Current yearPrevious yearGrowGrow %
Making money$5.6m$6.1m-$479.8k-8.5%
Net Profit Margin12.3%17.1%--

How much money comes from the company's main activities?

3. Financial Health of Biotage (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#70 / 169

Most Revenue
#99 / 169

Most Profit
#74 / 169

What can you expect buying and holding a share of Biotage? (5 min.)

Welcome investor! Biotage's management wants to use your money to grow the business. In return you get a share of Biotage.

What can you expect buying and holding a share of Biotage?

First you should know what it really means to hold a share of Biotage. And how you can make/lose money.

Speculation

The Price per Share of Biotage is kr165.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotage.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotage, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr45.66. Based on the TTM, the Book Value Change Per Share is kr6.30 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.66 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotage.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.150.1%0.070.0%0.080.0%0.060.0%0.050.0%
Usd Book Value Change Per Share-0.030.0%0.580.3%0.080.0%0.170.1%0.090.1%
Usd Dividend Per Share0.000.0%0.060.0%0.120.1%0.090.1%0.080.0%
Usd Total Gains Per Share-0.030.0%0.640.4%0.190.1%0.250.2%0.170.1%
Usd Price Per Share12.22-11.60-17.22-14.29-9.26-
Price to Earnings Ratio20.43-54.37-56.75-65.98-49.01-
Price-to-Total Gains Ratio-350.66-14.49-93.76-231.49-147.25-
Price to Book Ratio2.93-3.60-9.82-10.13-8.15-
Price-to-Total Gains Ratio-350.66-14.49-93.76-231.49-147.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.1267
Number of shares66
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.09
Usd Book Value Change Per Share0.580.17
Usd Total Gains Per Share0.640.25
Gains per Quarter (66 shares)42.0016.81
Gains per Year (66 shares)168.0167.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
116152158234557
2323043264589124
34845649468134191
46460866291178258
580760830114223325
696912998136267392
711210641166159312459
812812161334182356526
914413681502205401593
1016015201670227445660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%71.00.07.091.0%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%16.04.00.080.0%31.09.00.077.5%50.028.00.064.1%
Dividend per Share2.00.02.050.0%10.00.02.083.3%15.00.05.075.0%32.00.08.080.0%47.00.031.060.3%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%62.016.00.079.5%

Fundamentals of Biotage

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2024-04-19 16:57:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biotage AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotage earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Biotage to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 20.4% means that kr0.20 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotage AB:

  • The MRQ is 20.4%. The company is making a huge profit. +2
  • The TTM is 12.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.4%TTM12.3%+8.1%
TTM12.3%YOY17.1%-4.8%
TTM12.3%5Y15.8%-3.6%
5Y15.8%10Y15.2%+0.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ20.4%6.2%+14.2%
TTM12.3%6.2%+6.1%
YOY17.1%8.0%+9.1%
5Y15.8%7.3%+8.5%
10Y15.2%6.8%+8.4%
1.1.2. Return on Assets

Shows how efficient Biotage is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotage to the Medical Instruments & Supplies industry mean.
  • 2.7% Return on Assets means that Biotage generated kr0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotage AB:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.7%TTM1.5%+1.2%
TTM1.5%YOY3.0%-1.5%
TTM1.5%5Y2.9%-1.4%
5Y2.9%10Y3.2%-0.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7%1.3%+1.4%
TTM1.5%1.4%+0.1%
YOY3.0%1.9%+1.1%
5Y2.9%2.2%+0.7%
10Y3.2%2.0%+1.2%
1.1.3. Return on Equity

Shows how efficient Biotage is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotage to the Medical Instruments & Supplies industry mean.
  • 3.6% Return on Equity means Biotage generated kr0.04 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotage AB:

  • The MRQ is 3.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM2.0%+1.6%
TTM2.0%YOY4.3%-2.3%
TTM2.0%5Y4.2%-2.2%
5Y4.2%10Y4.4%-0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%2.6%+1.0%
TTM2.0%2.8%-0.8%
YOY4.3%3.7%+0.6%
5Y4.2%3.9%+0.3%
10Y4.4%3.9%+0.5%

1.2. Operating Efficiency of Biotage AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotage is operating .

  • Measures how much profit Biotage makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotage to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 23.6% means the company generated kr0.24  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotage AB:

  • The MRQ is 23.6%. The company is operating efficient. +1
  • The TTM is 16.4%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ23.6%TTM16.4%+7.2%
TTM16.4%YOY22.6%-6.1%
TTM16.4%5Y21.7%-5.2%
5Y21.7%10Y14.6%+7.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ23.6%7.9%+15.7%
TTM16.4%7.6%+8.8%
YOY22.6%10.9%+11.7%
5Y21.7%10.1%+11.6%
10Y14.6%10.5%+4.1%
1.2.2. Operating Ratio

Measures how efficient Biotage is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are kr0.76 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Biotage AB:

  • The MRQ is 0.764. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.835. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.764TTM0.835-0.071
TTM0.835YOY0.814+0.021
TTM0.8355Y1.028-0.193
5Y1.02810Y0.900+0.128
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7641.153-0.389
TTM0.8351.168-0.333
YOY0.8141.105-0.291
5Y1.0281.097-0.069
10Y0.9001.056-0.156

1.3. Liquidity of Biotage AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotage is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.05 means the company has kr2.05 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotage AB:

  • The MRQ is 2.052. The company is able to pay all its short-term debts. +1
  • The TTM is 2.140. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.052TTM2.140-0.087
TTM2.140YOY2.559-0.419
TTM2.1405Y2.716-0.576
5Y2.71610Y1.994+0.721
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0522.302-0.250
TTM2.1402.333-0.193
YOY2.5592.588-0.029
5Y2.7162.627+0.089
10Y1.9942.623-0.629
1.3.2. Quick Ratio

Measures if Biotage is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotage to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.39 means the company can pay off kr1.39 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotage AB:

  • The MRQ is 1.390. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.441. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.390TTM1.441-0.051
TTM1.441YOY1.697-0.255
TTM1.4415Y1.823-0.381
5Y1.82310Y1.454+0.369
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3901.098+0.292
TTM1.4411.127+0.314
YOY1.6971.306+0.391
5Y1.8231.430+0.393
10Y1.4541.533-0.079

1.4. Solvency of Biotage AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotage assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotage to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.26 means that Biotage assets are financed with 25.8% credit (debt) and the remaining percentage (100% - 25.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotage AB:

  • The MRQ is 0.258. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.264. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.258TTM0.264-0.006
TTM0.264YOY0.303-0.039
TTM0.2645Y0.307-0.043
5Y0.30710Y0.260+0.047
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2580.357-0.099
TTM0.2640.360-0.096
YOY0.3030.353-0.050
5Y0.3070.365-0.058
10Y0.2600.371-0.111
1.4.2. Debt to Equity Ratio

Measures if Biotage is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotage to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 34.8% means that company has kr0.35 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotage AB:

  • The MRQ is 0.348. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.360. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.348TTM0.360-0.011
TTM0.360YOY0.435-0.076
TTM0.3605Y0.446-0.087
5Y0.44610Y0.361+0.086
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3480.541-0.193
TTM0.3600.561-0.201
YOY0.4350.551-0.116
5Y0.4460.653-0.207
10Y0.3610.669-0.308

2. Market Valuation of Biotage AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Biotage generates.

  • Above 15 is considered overpriced but always compare Biotage to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 20.43 means the investor is paying kr20.43 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotage AB:

  • The EOD is 25.294. Based on the earnings, the company is overpriced. -1
  • The MRQ is 20.434. Based on the earnings, the company is fair priced.
  • The TTM is 54.372. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD25.294MRQ20.434+4.860
MRQ20.434TTM54.372-33.938
TTM54.372YOY56.755-2.383
TTM54.3725Y65.981-11.609
5Y65.98110Y49.011+16.970
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD25.29414.408+10.886
MRQ20.43415.934+4.500
TTM54.37216.376+37.996
YOY56.75522.147+34.608
5Y65.98120.830+45.151
10Y49.01125.069+23.942
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotage AB:

  • The EOD is 26.940. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.763. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -50.135. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.940MRQ21.763+5.176
MRQ21.763TTM-50.135+71.898
TTM-50.135YOY60.855-110.990
TTM-50.1355Y105.424-155.559
5Y105.42410Y63.884+41.540
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD26.9409.511+17.429
MRQ21.7639.241+12.522
TTM-50.1350.922-51.057
YOY60.8553.453+57.402
5Y105.4245.897+99.527
10Y63.884-0.177+64.061
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotage is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 2.93 means the investor is paying kr2.93 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotage AB:

  • The EOD is 3.624. Based on the equity, the company is fair priced.
  • The MRQ is 2.928. Based on the equity, the company is underpriced. +1
  • The TTM is 3.598. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.624MRQ2.928+0.696
MRQ2.928TTM3.598-0.670
TTM3.598YOY9.825-6.227
TTM3.5985Y10.133-6.535
5Y10.13310Y8.153+1.980
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD3.6242.448+1.176
MRQ2.9282.753+0.175
TTM3.5982.691+0.907
YOY9.8253.294+6.531
5Y10.1333.563+6.570
10Y8.1534.227+3.926
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biotage AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3816.301-106%0.828-146%1.844-121%0.993-138%
Book Value Per Share--45.66339.906+14%19.286+137%19.223+138%13.106+248%
Current Ratio--2.0522.140-4%2.559-20%2.716-24%1.994+3%
Debt To Asset Ratio--0.2580.264-2%0.303-15%0.307-16%0.260-1%
Debt To Equity Ratio--0.3480.360-3%0.435-20%0.446-22%0.361-3%
Dividend Per Share---0.662-100%1.275-100%0.943-100%0.848-100%
Eps--1.6360.768+113%0.834+96%0.675+142%0.501+226%
Free Cash Flow Per Share--1.5360.712+116%0.847+81%0.802+92%0.784+96%
Free Cash Flow To Equity Per Share--1.4360.268+436%0.431+233%0.420+242%0.574+150%
Gross Profit Margin--1.000-1.147+215%-0.434+143%0.189+428%0.595+68%
Intrinsic Value_10Y_max--67.306--------
Intrinsic Value_10Y_min--36.674--------
Intrinsic Value_1Y_max--3.816--------
Intrinsic Value_1Y_min--3.248--------
Intrinsic Value_3Y_max--13.698--------
Intrinsic Value_3Y_min--10.186--------
Intrinsic Value_5Y_max--26.270--------
Intrinsic Value_5Y_min--17.540--------
Market Cap13241357100.000+19%10707561841.20010156612559.400+5%15071544675.000-29%12513996875.880-14%8102387570.940+32%
Net Profit Margin--0.2040.123+66%0.171+19%0.158+29%0.152+34%
Operating Margin--0.2360.164+44%0.226+5%0.217+9%0.146+62%
Operating Ratio--0.7640.835-9%0.814-6%1.028-26%0.900-15%
Pb Ratio3.624+19%2.9283.598-19%9.825-70%10.133-71%8.153-64%
Pe Ratio25.294+19%20.43454.372-62%56.755-64%65.981-69%49.011-58%
Price Per Share165.500+19%133.700126.875+5%188.375-29%156.395-15%101.263+32%
Price To Free Cash Flow Ratio26.940+19%21.763-50.135+330%60.855-64%105.424-79%63.884-66%
Price To Total Gains Ratio-434.065-24%-350.66114.486-2521%93.760-474%231.489-251%147.253-338%
Quick Ratio--1.3901.441-4%1.697-18%1.823-24%1.454-4%
Return On Assets--0.0270.015+80%0.030-12%0.029-8%0.032-17%
Return On Equity--0.0360.020+78%0.043-17%0.042-15%0.044-18%
Total Gains Per Share---0.3816.963-105%2.103-118%2.787-114%1.841-121%
Usd Book Value--334249800.000292023000.000+14%141030200.000+137%140610811.100+138%95863160.255+249%
Usd Book Value Change Per Share---0.0350.576-106%0.076-146%0.169-121%0.091-138%
Usd Book Value Per Share--4.1743.647+14%1.763+137%1.757+138%1.198+248%
Usd Dividend Per Share---0.061-100%0.117-100%0.086-100%0.078-100%
Usd Eps--0.1500.070+113%0.076+96%0.062+142%0.046+226%
Usd Free Cash Flow--11242200.0005209800.000+116%6192350.000+82%5865019.180+92%5732137.290+96%
Usd Free Cash Flow Per Share--0.1400.065+116%0.077+81%0.073+92%0.072+96%
Usd Free Cash Flow To Equity Per Share--0.1310.025+436%0.039+233%0.038+242%0.052+150%
Usd Market Cap1210260038.940+19%978671152.286928314387.929+5%1377539183.295-29%1143779314.455-14%740558223.984+32%
Usd Price Per Share15.127+19%12.22011.596+5%17.217-29%14.295-15%9.255+32%
Usd Profit--11973400.0005621100.000+113%6100950.000+96%4936349.480+143%3664452.215+227%
Usd Revenue--58770200.00042546700.000+38%35805950.000+64%31324891.340+88%23506544.480+150%
Usd Total Gains Per Share---0.0350.636-105%0.192-118%0.255-114%0.168-121%
 EOD+3 -5MRQTTM+25 -11YOY+22 -145Y+22 -1410Y+25 -11

3.2. Fundamental Score

Let's check the fundamental score of Biotage AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1525.294
Price to Book Ratio (EOD)Between0-13.624
Net Profit Margin (MRQ)Greater than00.204
Operating Margin (MRQ)Greater than00.236
Quick Ratio (MRQ)Greater than11.390
Current Ratio (MRQ)Greater than12.052
Debt to Asset Ratio (MRQ)Less than10.258
Debt to Equity Ratio (MRQ)Less than10.348
Return on Equity (MRQ)Greater than0.150.036
Return on Assets (MRQ)Greater than0.050.027
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Biotage AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.996
Ma 20Greater thanMa 50170.215
Ma 50Greater thanMa 100173.594
Ma 100Greater thanMa 200154.524
OpenGreater thanClose163.100
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -224,00017,000-207,000137,000-70,000-23,000-93,000126,00033,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets4,931,000
Total Liabilities1,274,000
Total Stockholder Equity3,657,000
 As reported
Total Liabilities 1,274,000
Total Stockholder Equity+ 3,657,000
Total Assets = 4,931,000

Assets

Total Assets4,931,000
Total Current Assets1,447,000
Long-term Assets3,484,000
Total Current Assets
Cash And Cash Equivalents 594,000
Net Receivables 386,000
Inventory 437,000
Other Current Assets 30,000
Total Current Assets  (as reported)1,447,000
Total Current Assets  (calculated)1,447,000
+/-0
Long-term Assets
Property Plant Equipment 284,000
Goodwill 2,391,000
Long-term Assets Other 759,000
Long-term Assets  (as reported)3,484,000
Long-term Assets  (calculated)3,434,000
+/- 50,000

Liabilities & Shareholders' Equity

Total Current Liabilities705,000
Long-term Liabilities569,000
Total Stockholder Equity3,657,000
Total Current Liabilities
Short-term Debt 254,000
Accounts payable 98,000
Other Current Liabilities 255,000
Total Current Liabilities  (as reported)705,000
Total Current Liabilities  (calculated)607,000
+/- 98,000
Long-term Liabilities
Long-term Liabilities  (as reported)569,000
Long-term Liabilities  (calculated)0
+/- 569,000
Total Stockholder Equity
Common Stock112,000
Retained Earnings 1,378,000
Accumulated Other Comprehensive Income -124,000
Other Stockholders Equity 2,291,000
Total Stockholder Equity (as reported)3,657,000
Total Stockholder Equity (calculated)3,657,000
+/-0
Other
Cash and Short Term Investments 594,000
Common Stock Shares Outstanding 80,086
Current Deferred Revenue98,000
Liabilities and Stockholders Equity 4,931,000
Net Debt 33,000
Net Working Capital 742,000
Short Long Term Debt Total 627,000



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-12-312000-06-30
> Total Assets 
965,290
953,473
911,049
846,817
757,406
678,036
587,186
826,653
754,723
742,411
718,127
695,151
726,971
1,019,516
1,052,640
974,738
935,959
916,217
927,757
917,265
942,163
953,533
939,365
988,599
959,164
959,928
1,002,645
1,299,012
1,301,744
1,269,395
1,218,714
1,227,390
1,173,307
1,206,522
1,117,283
693,427
677,354
648,765
674,409
699,054
678,712
663,911
651,855
654,074
639,619
591,563
571,802
592,247
608,720
586,599
603,635
619,010
652,626
616,262
637,606
668,832
684,841
633,607
658,227
695,196
725,120
673,424
699,575
757,201
941,776
915,432
955,980
1,003,203
1,285,212
1,278,048
1,342,128
1,335,687
1,427,899
1,386,519
1,420,427
1,434,441
1,575,808
1,409,615
1,503,000
1,992,000
2,056,000
2,158,000
2,306,000
2,339,000
2,362,000
5,002,000
5,001,000
4,931,000
4,931,0005,001,0005,002,0002,362,0002,339,0002,306,0002,158,0002,056,0001,992,0001,503,0001,409,6151,575,8081,434,4411,420,4271,386,5191,427,8991,335,6871,342,1281,278,0481,285,2121,003,203955,980915,432941,776757,201699,575673,424725,120695,196658,227633,607684,841668,832637,606616,262652,626619,010603,635586,599608,720592,247571,802591,563639,619654,074651,855663,911678,712699,054674,409648,765677,354693,4271,117,2831,206,5221,173,3071,227,3901,218,7141,269,3951,301,7441,299,0121,002,645959,928959,164988,599939,365953,533942,163917,265927,757916,217935,959974,7381,052,6401,019,516726,971695,151718,127742,411754,723826,653587,186678,036757,406846,817911,049953,473965,290
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
355,980
388,343
334,957
358,483
409,252
447,109
406,982
445,061
494,438
513,066
513,986
564,639
586,569
655,111
644,456
701,921
751,615
851,273
694,254
784,000
774,000
842,000
902,000
1,008,000
1,031,000
1,034,000
1,288,000
1,379,000
1,447,000
1,447,0001,379,0001,288,0001,034,0001,031,0001,008,000902,000842,000774,000784,000694,254851,273751,615701,921644,456655,111586,569564,639513,986513,066494,438445,061406,982447,109409,252358,483334,957388,343355,98000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,622
152,097
101,637
119,552
174,263
168,889
95,844
134,059
177,020
142,603
108,080
131,875
185,867
231,122
260,692
316,145
371,325
422,068
278,552
359,000
311,000
349,000
312,000
388,000
441,000
426,000
444,000
501,000
594,000
594,000501,000444,000426,000441,000388,000312,000349,000311,000359,000278,552422,068371,325316,145260,692231,122185,867131,875108,080142,603177,020134,05995,844168,889174,263119,552101,637152,097128,62200000000000000000000000000000000000000000000000000000000000
       Net Receivables 
11,766
28,292
34,393
37,590
19,890
37,035
21,928
74,449
66,265
73,064
69,781
72,189
67,242
105,114
108,827
100,285
97,084
100,181
104,936
91,278
95,152
110,443
97,014
112,203
99,971
108,175
116,415
93,713
80,272
88,970
96,751
117,527
88,411
108,862
99,158
121,762
91,605
93,958
104,306
99,343
109,184
105,464
105,659
93,437
92,920
103,529
89,298
94,427
107,300
101,388
102,167
103,762
119,739
118,143
116,241
120,963
121,322
129,988
136,702
133,973
146,699
142,516
146,959
135,630
164,932
190,848
184,775
180,683
221,714
256,325
262,075
221,622
237,999
207,802
215,175
213,099
237,214
221,377
217,000
180,000
216,000
263,000
253,000
287,000
306,000
408,000
370,000
386,000
386,000370,000408,000306,000287,000253,000263,000216,000180,000217,000221,377237,214213,099215,175207,802237,999221,622262,075256,325221,714180,683184,775190,848164,932135,630146,959142,516146,699133,973136,702129,988121,322120,963116,241118,143119,739103,762102,167101,388107,30094,42789,298103,52992,92093,437105,659105,464109,18499,343104,30693,95891,605121,76299,158108,86288,411117,52796,75188,97080,27293,713116,415108,17599,971112,20397,014110,44395,15291,278104,936100,18197,084100,285108,827105,11467,24272,18969,78173,06466,26574,44921,92837,03519,89037,59034,39328,29211,766
       Other Current Assets 
1,503
18,038
18,604
15,003
12,298
14,219
4,978
4,865
0
0
0
4,103
0
0
0
5,312
1
0
1
3,083
0
0
0
3,842
0
0
0
6,785
0
0
0
3,700
0
0
0
3,824
0
0
0
6,908
0
0
0
3,656
1
0
1
3,432
0
0
0
2,850
1
0
0
3,574
0
0
0
4,479
0
0
0
3,565
1
0
0
0
0
0
0
-1
0
1
0
-1
-1
-1
0
226,000
249,000
302,000
61,000
-2,000
77,000
100,000
91,000
30,000
30,00091,000100,00077,000-2,00061,000302,000249,000226,0000-1-1-1010-100000013,5650004,4790003,5740012,8500003,4321013,6560006,9080003,8240003,7000006,7850003,8420003,0831015,3120004,1030004,8654,97814,21912,29815,00318,60418,0381,503
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
772,146
764,062
777,489
749,118
772,788
742,064
718,506
682,826
724,534
715,360
719,000
1,218,000
1,214,000
1,256,000
1,298,000
1,308,000
1,328,000
3,714,000
3,622,000
3,484,000
3,484,0003,622,0003,714,0001,328,0001,308,0001,298,0001,256,0001,214,0001,218,000719,000715,360724,534682,826718,506742,064772,788749,118777,489764,062772,14600000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
15,512
35,959
51,986
55,072
53,612
51,271
46,633
107,603
102,069
103,767
96,616
89,327
89,591
120,186
115,685
113,424
0
101,883
101,308
95,333
93,900
90,868
86,192
84,987
78,625
78,370
81,768
80,978
83,500
82,655
41,827
41,915
39,372
35,471
32,803
35,330
34,569
35,296
38,478
39,468
41,953
42,370
41,239
40,695
39,288
40,554
40,960
41,608
43,204
44,009
43,266
43,057
43,093
41,957
43,903
44,719
41,567
39,927
39,737
45,447
44,690
44,284
44,593
45,303
47,328
49,116
48,299
48,630
115,875
110,599
110,513
112,253
110,637
109,743
107,977
103,656
126,050
125,751
124,000
127,000
126,000
127,000
138,000
162,000
166,000
264,000
290,000
284,000
284,000290,000264,000166,000162,000138,000127,000126,000127,000124,000125,751126,050103,656107,977109,743110,637112,253110,513110,599115,87548,63048,29949,11647,32845,30344,59344,28444,69045,44739,73739,92741,56744,71943,90341,95743,09343,05743,26644,00943,20441,60840,96040,55439,28840,69541,23942,37041,95339,46838,47835,29634,56935,33032,80335,47139,37241,91541,82782,65583,50080,97881,76878,37078,62584,98786,19290,86893,90095,333101,308101,8830113,424115,685120,18689,59189,32796,616103,767102,069107,60346,63351,27153,61255,07251,98635,95915,512
       Goodwill 
0
0
0
0
0
0
0
402,567
392,251
376,119
359,989
322,209
385,752
493,580
490,757
503,510
497,098
480,530
484,084
471,839
477,027
474,001
461,755
460,593
442,175
443,637
465,685
487,227
503,294
493,959
467,135
473,661
469,857
573,096
548,320
104,791
99,842
100,000
105,453
106,108
103,101
106,504
102,182
102,054
102,060
104,023
101,200
104,023
104,023
104,023
104,023
90,523
90,523
90,523
90,523
104,023
104,023
104,023
104,023
104,023
104,023
104,023
104,023
104,023
180,464
185,954
185,016
186,055
315,073
314,827
326,955
315,868
333,149
316,594
308,393
290,209
302,381
297,524
304,000
741,000
746,000
776,000
804,000
794,000
801,000
2,575,000
2,491,000
2,391,000
2,391,0002,491,0002,575,000801,000794,000804,000776,000746,000741,000304,000297,524302,381290,209308,393316,594333,149315,868326,955314,827315,073186,055185,016185,954180,464104,023104,023104,023104,023104,023104,023104,023104,023104,02390,52390,52390,52390,523104,023104,023104,023104,023101,200104,023102,060102,054102,182106,504103,101106,108105,453100,00099,842104,791548,320573,096469,857473,661467,135493,959503,294487,227465,685443,637442,175460,593461,755474,001477,027471,839484,084480,530497,098503,510490,757493,580385,752322,209359,989376,119392,251402,5670000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,645
21,157
20,728
20,329
17,838
20,240
19,996
18,697
17,368
18,952
17,228
17,260
16,614
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000016,61417,26017,22818,95217,36818,69719,99620,24017,83820,32920,72821,15718,64500000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
12,202
11,851
25,734
24,188
71,582
20,228
22,862
423,750
413,253
398,818
382,943
353,208
406,871
526,024
523,110
536,114
562,095
548,376
551,662
503,545
556,786
503,752
490,292
488,222
468,805
468,261
489,303
503,490
518,749
508,327
480,512
485,706
481,057
632,496
600,020
155,406
147,342
146,119
153,053
153,527
148,301
152,004
144,482
143,088
142,011
143,423
138,900
141,573
140,723
138,923
138,223
123,865
122,823
121,923
120,723
133,226
132,323
131,323
130,323
129,238
127,923
127,623
126,823
127,631
267,430
90,536
90,774
91,447
264,893
262,645
267,972
260,047
271,386
263,022
257,511
250,787
259,790
257,747
257,000
313,000
309,000
315,000
319,000
309,000
308,000
821,000
791,000
0
0791,000821,000308,000309,000319,000315,000309,000313,000257,000257,747259,790250,787257,511263,022271,386260,047267,972262,645264,89391,44790,77490,536267,430127,631126,823127,623127,923129,238130,323131,323132,323133,226120,723121,923122,823123,865138,223138,923140,723141,573138,900143,423142,011143,088144,482152,004148,301153,527153,053146,119147,342155,406600,020632,496481,057485,706480,512508,327518,749503,490489,303468,261468,805488,222490,292503,752556,786503,545551,662548,376562,095536,114523,110526,024406,871353,208382,943398,818413,253423,75022,86220,22871,58224,18825,73411,85112,202
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
772,146
764,062
777,489
1
-1
0
-2
3
-1
-1
1,000
15,000
15,000
16,000
15,000
20,000
-1,000
-1,000
19,000
759,000
759,00019,000-1,000-1,00020,00015,00016,00015,00015,0001,000-1-13-20-11777,489764,062772,14600000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
32,100
51,109
46,785
61,834
55,369
61,875
43,679
217,154
184,644
197,655
211,094
172,025
171,715
391,904
362,539
236,486
220,279
215,505
215,104
204,791
216,998
193,736
182,486
192,334
171,670
162,890
164,354
174,219
174,297
168,655
156,544
138,363
89,754
130,629
126,636
125,480
122,724
121,267
126,372
135,157
132,924
127,410
123,150
123,244
121,468
122,638
108,765
115,473
124,093
121,874
122,875
116,360
121,988
120,166
123,521
122,175
120,655
123,341
118,714
131,958
129,181
127,749
129,936
148,590
282,223
283,033
282,404
301,023
457,581
495,984
474,645
460,185
469,649
424,262
431,237
444,403
493,494
390,114
413,000
620,000
601,000
677,000
707,000
702,000
674,000
1,256,000
1,312,000
1,274,000
1,274,0001,312,0001,256,000674,000702,000707,000677,000601,000620,000413,000390,114493,494444,403431,237424,262469,649460,185474,645495,984457,581301,023282,404283,033282,223148,590129,936127,749129,181131,958118,714123,341120,655122,175123,521120,166121,988116,360122,875121,874124,093115,473108,765122,638121,468123,244123,150127,410132,924135,157126,372121,267122,724125,480126,636130,62989,754138,363156,544168,655174,297174,219164,354162,890171,670192,334182,486193,736216,998204,791215,104215,505220,279236,486362,539391,904171,715172,025211,094197,655184,644217,15443,67961,87555,36961,83446,78551,10932,100
   > Total Current Liabilities 
31,940
50,988
46,659
59,093
50,831
61,505
43,335
151,424
127,345
143,443
154,939
128,787
127,374
340,072
311,739
179,366
157,839
155,525
155,157
154,105
159,153
143,814
136,161
151,406
134,717
126,199
152,684
142,036
160,914
156,745
117,250
98,632
80,347
105,568
88,562
87,645
88,475
89,577
92,502
104,123
102,099
95,929
94,154
92,190
91,643
93,517
79,926
87,950
95,379
99,306
100,450
102,916
108,567
110,745
114,460
117,684
116,359
119,126
114,542
127,721
125,124
123,735
126,010
144,377
155,847
155,958
155,772
173,397
200,070
199,806
220,261
212,272
200,402
186,373
195,158
217,363
246,434
263,719
289,000
313,000
298,000
371,000
402,000
417,000
377,000
689,000
728,000
705,000
705,000728,000689,000377,000417,000402,000371,000298,000313,000289,000263,719246,434217,363195,158186,373200,402212,272220,261199,806200,070173,397155,772155,958155,847144,377126,010123,735125,124127,721114,542119,126116,359117,684114,460110,745108,567102,916100,45099,30695,37987,95079,92693,51791,64392,19094,15495,929102,099104,12392,50289,57788,47587,64588,562105,56880,34798,632117,250156,745160,914142,036152,684126,199134,717151,406136,161143,814159,153154,105155,157155,525157,839179,366311,739340,072127,374128,787154,939143,443127,345151,42443,33561,50550,83159,09346,65950,98831,940
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109,288
109,325
0
0
0
18,122
0
0
0
0
0
0
0
0
0
23,000
23,000
22,000
23,000
25,000
23,000
22,000
30,000
254,000
254,00030,00022,00023,00025,00023,00022,00023,00023,00000000000018,122000109,325109,2880000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109,288
109,325
0
0
0
18,122
0
0
0
0
0
0
0
23,289
0
0
0
0
0
0
0
0
0
0
000000000023,289000000018,122000109,325109,2880000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
8,936
27,860
18,180
32,101
14,712
18,419
11,290
53,636
0
0
0
47,548
35,531
44,973
39,247
40,980
34,873
40,832
36,082
37,418
50,217
99,989
95,918
46,339
100,014
92,753
96,450
40,521
84,880
0
82,600
45,248
74,218
98,808
83,431
26,741
79,882
83,086
86,606
44,535
96,766
90,812
87,097
37,912
87,917
90,902
76,499
31,609
89,675
90,524
91,696
33,910
103,666
103,916
106,835
32,936
110,189
114,652
110,678
38,133
121,261
118,629
120,563
47,457
150,761
150,304
149,951
54,764
158,081
158,389
178,134
41,461
166,150
155,580
160,357
51,236
53,503
46,030
54,000
56,000
43,000
75,000
74,000
57,000
64,000
139,000
174,000
98,000
98,000174,000139,00064,00057,00074,00075,00043,00056,00054,00046,03053,50351,236160,357155,580166,15041,461178,134158,389158,08154,764149,951150,304150,76147,457120,563118,629121,26138,133110,678114,652110,18932,936106,835103,916103,66633,91091,69690,52489,67531,60976,49990,90287,91737,91287,09790,81296,76644,53586,60683,08679,88226,74183,43198,80874,21845,24882,600084,88040,52196,45092,753100,01446,33995,91899,98950,21737,41836,08240,83234,87340,98039,24744,97335,53147,54800053,63611,29018,41914,71232,10118,18027,8608,936
       Other Current Liabilities 
23,004
23,128
28,479
26,992
36,119
43,086
32,045
97,788
0
0
0
61,730
91,843
93,675
101,384
96,413
122,966
114,693
119,075
81,803
108,936
7,202
7,500
70,326
5,801
5,603
8,113
62,686
29,805
2,818,682
22,755
52,469
5,418
6,276
4,353
60,468
8,172
6,071
5,455
59,146
4,894
4,666
6,618
53,844
3,317
2,191
2,998
55,897
5,256
8,308
8,267
68,504
4,187
6,078
6,466
84,748
6,170
4,474
3,864
89,588
3,863
5,106
5,447
96,920
5,086
5,654
5,821
58,222
23,808
-1
1
80,245
12,831
9,875
12,958
86,434
170,278
194,400
211,000
234,000
232,000
274,000
305,000
335,000
290,000
514,000
286,000
255,000
255,000286,000514,000290,000335,000305,000274,000232,000234,000211,000194,400170,27886,43412,9589,87512,83180,2451-123,80858,2225,8215,6545,08696,9205,4475,1063,86389,5883,8644,4746,17084,7486,4666,0784,18768,5048,2678,3085,25655,8972,9982,1913,31753,8446,6184,6664,89459,1465,4556,0718,17260,4684,3536,2765,41852,46922,7552,818,68229,80562,6868,1135,6035,80170,3267,5007,202108,93681,803119,075114,693122,96696,413101,38493,67591,84361,73000097,78832,04543,08636,11926,99228,47923,12823,004
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
257,511
296,178
254,384
247,913
269,246
237,889
236,079
227,039
247,059
126,395
125,000
307,000
303,000
306,000
305,000
285,000
297,000
567,000
584,000
569,000
569,000584,000567,000297,000285,000305,000306,000303,000307,000125,000126,395247,059227,039236,079237,889269,246247,913254,384296,178257,51100000000000000000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
140,677
153,626
40,861
37,000
180,000
175,000
172,000
174,000
192,000
196,000
196,000
221,000
0
0221,000196,000196,000192,000174,000172,000175,000180,00037,00040,861153,626140,677000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
2,652
0
370
0
32,740
23,989
21,117
16,011
8,570
7,872
11,770
11,640
1,691
9,107
10,114
10,157
3,877
10,934
4,128
3,260
3,776
3,327
3,381
2,716
24,118
5,064
3,047
31,674
32,116
2,308
17,629
31,390
31,434
28,222
25,829
27,866
25,184
25,172
25,834
23,657
24,178
23,499
21,940
21,851
20,395
22,349
15,990
15,844
6,442
6,441
2,540
2,501
2,543
2,457
2,422
2,414
2,478
2,306
2,280
2,216
2,592
2,676
17,750
17,269
18,226
104,464
107,269
105,784
100,265
125,050
89,710
89,502
86,363
93,436
39,622
40,000
128,000
82,000
85,000
78,000
76,000
90,000
0
205,000
0
0205,000090,00076,00078,00085,00082,000128,00040,00039,62293,43686,36389,50289,710125,050100,265105,784107,269104,46418,22617,26917,7502,6762,5922,2162,2802,3062,4782,4142,4222,4572,5432,5012,5406,4416,44215,84415,99022,34920,39521,85121,94023,49924,17823,65725,83425,17225,18427,86625,82928,22231,43431,39017,6292,30832,11631,6743,0475,06424,1182,7163,3813,3273,7763,2604,12810,9343,87710,15710,1149,1071,69111,64011,7707,8728,57016,01121,11723,98932,740037002,652000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,800
90,665
92,254
92,079
95,038
98,700
100,800
102,800
101,207
99,900
100,900
102,900
105,492
109,800
114,800
117,100
122,073
127,144
129,936
129,000
128,000
129,000
131,000
133,000
136,000
143,000
0
157,000
0
0157,0000143,000136,000133,000131,000129,000128,000129,000129,936127,144122,073117,100114,800109,800105,492102,900100,90099,900101,207102,800100,80098,70095,03892,07992,25490,66590,80000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
933,190
902,364
864,264
784,983
702,037
616,161
543,507
609,499
570,079
544,756
507,033
523,126
555,256
627,612
690,101
738,252
715,680
700,712
712,653
712,474
725,165
759,797
756,879
796,265
787,494
797,038
838,291
1,124,793
1,127,447
1,100,740
1,062,170
1,089,027
1,083,553
1,075,893
990,647
567,947
554,630
527,498
548,037
563,897
545,788
536,501
528,705
530,830
518,151
468,925
463,037
476,774
484,627
464,725
480,760
502,650
530,638
496,096
514,085
546,657
564,186
510,266
539,513
563,238
595,939
545,675
569,639
608,611
659,553
632,399
673,576
702,180
827,631
782,064
867,483
875,502
958,250
962,257
989,190
990,038
1,082,314
1,019,501
1,090,000
1,372,000
1,455,000
1,481,000
1,599,000
1,637,000
1,688,000
3,746,000
3,689,000
3,657,000
3,657,0003,689,0003,746,0001,688,0001,637,0001,599,0001,481,0001,455,0001,372,0001,090,0001,019,5011,082,314990,038989,190962,257958,250875,502867,483782,064827,631702,180673,576632,399659,553608,611569,639545,675595,939563,238539,513510,266564,186546,657514,085496,096530,638502,650480,760464,725484,627476,774463,037468,925518,151530,830528,705536,501545,788563,897548,037527,498554,630567,947990,6471,075,8931,083,5531,089,0271,062,1701,100,7401,127,4471,124,793838,291797,038787,494796,265756,879759,797725,165712,474712,653700,712715,680738,252690,101627,612555,256523,126507,033544,756570,079609,499543,507616,161702,037784,983864,264902,364933,190
   Common Stock
0
34,768
0
34,770
0
34,770
0
57,792
0
0
0
64,042
0
0
0
88,486
715,680
700,712
712,653
88,486
725,165
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
88,486
89,194
89,194
89,194
89,194
89,372
89,372
89,372
89,372
89,423
89,423
89,423
89,423
89,954
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
89,953
90,630
90,630
90,630
90,630
90,630
90,630
90,969
90,969
90,969
90,969
91,000
92,000
92,000
92,000
92,000
93,000
93,000
112,000
112,000
112,000
112,000112,000112,00093,00093,00092,00092,00092,00092,00091,00090,96990,96990,96990,96990,63090,63090,63090,63090,63090,63089,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95389,95489,42389,42389,42389,42389,37289,37289,37289,37289,19489,19489,19489,19488,48688,48688,48688,48688,48688,48688,48688,48688,48688,48688,48688,48688,48688,48688,48688,486725,16588,486712,653700,712715,68088,48600064,04200057,792034,770034,770034,7680
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,000
146,000
45,000
-124,000
-124,00045,000146,00040,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,970
57,970
58,851
59,502
60,137
61,239
64,000
266,000
269,000
272,000
277,000
281,000
282,000
2,289,000
2,291,000
0
02,291,0002,289,000282,000281,000277,000272,000269,000266,00064,00061,23960,13759,50258,85157,97057,970000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-83,938
-86,530
-93,578
-100,741
-96,419
-90,330
-78,303
-81,153
-79,877
-2,618
-62,529
-43,744
-54,218
-32,817
-61,034
-72,340
-116,547
-84,947
-97,032
-82,000
217,000
229,000
299,000
352,000
315,000
282,000
2,289,000
2,291,000
2,291,000
2,291,0002,291,0002,289,000282,000315,000352,000299,000229,000217,000-82,000-97,032-84,947-116,547-72,340-61,034-32,817-54,218-43,744-62,529-2,618-79,877-81,153-78,303-90,330-96,419-100,741-93,578-86,530-83,93800000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,862,000
Cost of Revenue-849,000
Gross Profit1,013,0001,013,000
 
Operating Income (+$)
Gross Profit1,013,000
Operating Expense-637,000
Operating Income376,000376,000
 
Operating Expense (+$)
Research Development95,000
Selling General Administrative622,000
Selling And Marketing Expenses0
Operating Expense637,000717,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-11,000
Other Finance Cost-16,000
Net Interest Income5,000
 
Pretax Income (+$)
Operating Income376,000
Net Interest Income5,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)303,000449,000
EBIT - interestExpense = 365,000
303,000
257,000
Interest Expense11,000
Earnings Before Interest and Taxes (EBIT)376,000314,000
Earnings Before Interest and Taxes (EBITDA)525,000
 
After tax Income (+$)
Income Before Tax303,000
Tax Provision-53,000
Net Income From Continuing Ops189,000250,000
Net Income246,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,486,000
Total Other Income/Expenses Net-73,000-5,000
 

Technical Analysis of Biotage
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotage. The general trend of Biotage is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotage's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotage AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 165.20 < 166.60 < 170.40.

The bearish price targets are: 142.40 > 139.70 > 130.40.

Tweet this
Biotage AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotage AB. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotage AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotage AB. The current macd is -2.96018282.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotage price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biotage. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biotage price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biotage AB Daily Moving Average Convergence/Divergence (MACD) ChartBiotage AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotage AB. The current adx is 24.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biotage shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Biotage AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotage AB. The current sar is 169.27.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biotage AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotage AB. The current rsi is 45.00. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Biotage AB Daily Relative Strength Index (RSI) ChartBiotage AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotage AB. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotage price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biotage AB Daily Stochastic Oscillator ChartBiotage AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotage AB. The current cci is -79.95564974.

Biotage AB Daily Commodity Channel Index (CCI) ChartBiotage AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotage AB. The current cmo is -9.65668603.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biotage AB Daily Chande Momentum Oscillator (CMO) ChartBiotage AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotage AB. The current willr is -60.92436975.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biotage is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biotage AB Daily Williams %R ChartBiotage AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotage AB.

Biotage AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotage AB. The current atr is 5.9872847.

Biotage AB Daily Average True Range (ATR) ChartBiotage AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotage AB. The current obv is 3,324,026.

Biotage AB Daily On-Balance Volume (OBV) ChartBiotage AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotage AB. The current mfi is 59.09.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biotage AB Daily Money Flow Index (MFI) ChartBiotage AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotage AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Biotage AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotage AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.996
Ma 20Greater thanMa 50170.215
Ma 50Greater thanMa 100173.594
Ma 100Greater thanMa 200154.524
OpenGreater thanClose163.100
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biotage with someone you think should read this too:
  • Are you bullish or bearish on Biotage? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotage? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotage AB

I send you an email if I find something interesting about Biotage AB.


Comments

How you think about this?

Leave a comment

Stay informed about Biotage AB.

Receive notifications about Biotage AB in your mailbox!